Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to Extraordinary General Meeting in ExpreS2ion Biotech Holding AB (publ)

The shareholders of ExpreS2ion Biotech Holding AB, 559033-3729, are hereby invited to attend an Extraordinary General Meeting on Tuesday, March 19, 2019, at 10.00 at c/o Mazars SET, Terminalgatan 1, in Helsingborg.Right to participate and registration Shareholders who wish to attend the General Meeting shall · be entered in the share register on Wednesday the 13th of March 2019, and · sign up to the Company no later than Wednesday the 13th of March 2019 in writing to ExpreS2ion Biotech Holding AB, att: Extraordinary General Meeting, c/o Mazars SET, Terminalgatan 1, 252 78

Borr Drilling Limited (BDRILL) Announces Preliminary Results for the Fourth Quarter and Year Ended 2018

Hamilton, Bermuda, February 28, 2019: Borr Drilling Limited (“Borr” or the “Company”) announces preliminary results for the three and twelve months ended December 31, 2018 Highlights in the fourth quarter 2018 ·  Operating revenues of US$53.5 million, EBITDA of negative US$18.7 million and net loss of US$110.7 million for the fourth quarter of 2018 ·  Operating revenues of US$164.9 million, EBITDA of negative US$65.8 million and net loss of US$190.9 million for the year ended December 31, 2018 ·  Technical utilisation for the operating rigs was 99.6% in the fourth quarter of

ExpreS2ion conducts a directed share issue to accelerate the development of the company

ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces that the Company is conducting a directed share issue to a number of existing shareholders and strategic investors of initially approx. SEK 8 million, with attached consideration-free warrants, which in later stages can provide the Company with a further approx. SEK 9.6 million. The directed share issue is conducted in order to finance an accelerated pace of operations and increased investments in the business to ensure long-term good development. The motive to deviate from the shareholders' preferential rights is that considers it

EAB Group Plc's financial statements bulletin for 2018 - Group's comparable net turnover** grew 23% and AuM 8%

EAB Group Plc, Company Announcement, 28 February 2019, 9:00 a.m. (EET) EAB Group Plc's financial statements bulletin for 2018 - Group's comparable net turnover** grew 23% and AuM 8% EAB Group's (hereinafter EAB or Group) IFRS turnover during 1 January-31 December 2018 period amounted to EUR 19.6 million (EUR 17.6 million in 2017) and profit for the financial year amounted to EUR 1.4 million (-EUR 2.3 million). The Group's operating profit was EUR 1.8 million (-EUR 2.6 million in 2017). Turnover comprised fee income from fund management amounting to EUR 12.5 million (EUR 9.4 million),

ExpreS2ion Biotech Holding AB: Publication of financial report for January – December 2018

ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby publishes financial report for the period of January – December 2018. The report is available as an attached document to this press release and on the Company’s website (www.expres2ionbio.com). Below is a summary of the report.CEO Dr. Steen Klysner comments “In 2018 we focused on the continued expansion of our core platform by developing and including new technologies, as well as strengthening our joint venture AdaptVac. We have succeeded well with these activities and have documented good progress in a number of existing and new

Year End Report 2018 Azelio AB

2018 was a positive and eventful year for Azelio. The demonstration of the Company’s proprietary energy storage technology attracted attention from around the world, resulting in enquiries from potential customers in over 50 countries. The Company’s development and industrialization is continuing according to plan towards a full-scale verification project later this year, smaller commercial projects next year followed by a ramp up in volumes. In the fourth quarter Azelio was listed on Nasdaq First North. With the listing, the company brought in 242 million SEK before transaction costs and 2,

Increased numbers of shares and votes in Catena Media plc

The number of shares and votes in Catena Media plc amounts to 56,777,004 shares and votes following a directed share issue of 468,132 shares.Catena Media has, as announced on 13 February 2019 , resolved on a directed share issue of 468,132 shares as payment of part of the upfront purchase price for acquired assets in Baybets Ltd. The share issue has been registered with Maltese authorities in February 2019. Subsequent to the share issue, the

DOME ENERGY PRESENTS INTERIM REPORT FOR JULY-DECEMBER 2018

SECOND HALF-YEAR · Revenue from oil & gas production incl. realized derivatives $5,015’ (4,245’). · Effect from unrealized derivatives of $1 947’ (-338). · Gross result from production incl. realized derivatives $2,710’ (1,511’) with a margin of 54% (36%). · EBITDA of $1,405’ (-839’). · EBITDA for US operations adj. for unrealized derivatives amounted -$5’ (- 9’). · Net result of -$11,840’ (20,543’). · Earnings per share -$1.60 (4.38). FULL YEAR · Revenue from oil & gas production incl. realized derivatives $9,639’ (7,952’). · Effect from unrealized

Notice of the Annual General Meeting of Cloetta AB (publ)

Shareholders of Cloetta AB (publ), 556308-8144, are hereby invited to attend the Annual General Meeting, to be held on Thursday, 4 April 2019 at 3:00 p.m. at Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4 in Stockholm, Sweden.Notification of attendance Shareholders who wish to attend the Annual General Meeting must, firstly, be listed in the shareholders' register maintained by Euroclear Sweden AB (the Swedish Central Securities Depository), on Friday, 29 March 2019, and secondly, give notice to the company of their intention to attend the meeting no later than Friday, 29

Scout Gaming year-end report: foundation for future growth

” Scout operator trading index (consisting of total income from Scout Gaming's customers) for the fourth quarter amounted to 625, which is an increase of 242% compared with the corresponding quarter last year. Compared with the previous quarter, the increase is approximately 34%. Net sales for the full year increased from SEK 3.1 m to 7.1. Gambling within fantasy sports is still a premature market outside the US. However, we see a significant increase in demand from both operators and end users, which is very satisfactory. Growth will be driven by additional launches, but also increasing

MPC Container Ships ASA reports Q4 and twelve-month 2018 results and announces initiation of share buy-back programme

·  FY 2018 EBITDA USD 45.3 million. ·  FY 2018 net loss USD -1.6 million.  ·  Equity ratio 63.6% as of 31 December 2018.  Oslo, 28 February 2019 Q4 and twelve-month 2018 results: MPC Container Ships ASA ("MPCC" or the "Company", together with its subsidiaries the "Group") today published its unaudited financial report for the twelve-month period ended 31 December 2018. The Group reports a net loss of USD -1.6 million for Q1 – Q4 2018. ·  Total revenue was USD 52.5 million in Q4 2018 (Q3 2018: USD 55.8 million). For FY 2018, total revenue was USD 183.5 million. ·

Notice of Annual General Meeting in Hexagon AB (publ)

The shareholders of Hexagon AB are hereby invited to attend the Annual General Meeting to be held at 13:00 CET, Monday 8 April 2019, at City Conference Center Stockholm (Norra Latin), Drottninggatan 71 B, Stockholm. Shareholders who wish to attend the Annual General Meeting must:(i) be recorded in the share register maintained by Euroclear Sweden AB on Tuesday 2 April 2019, and(ii) notify the company of their intention to attend the Annual General Meeting by filling out a form at Hexagon’s website, www.hexagon.com, or by post to: Hexagon AB, “Annual General Meeting”, c/o Euroclear

Exel Composites’ Annual Financial Report 2018 published

EXEL COMPOSITES PLC     ANNUAL FINANCIAL REPORT    28 FEBRUARY 2019 at 09:00 EETExel Composites has today 28 February 2019 published its Annual Financial Report for 2018. The Annual Financial Report for the period from 1 January to 31 December 2018 includes the Board of Directors’ Report, the review by the President and CEO, the consolidated financial statements, the financial statements of the parent company and the auditor’s report. Exel Composites has today also published a Corporate Governance Statement and a Remuneration Statement for 2018. The above mentioned publications are

Q4 2018 Interim financial report North Investment Group AB (publ)

Highlights  · Robust commercial momentum across all business areas: Strong growth in Norway (20.6%), Sweden somewhat behind 2017 (-4.6%) due to currency effects and public sector delays · Group revenue of SEK 190m during the quarter (+7.1%) and SEK 746m for the year (+1.3%) · EBITDA of SEK 18m in Q4, record-high of SEK 89m in 2018 (+118%, SEK 14m above budget) · Strong order backlog of SEK 103m per Q4 2018 (+19%) · Continued margin improvement as outsourcing strategy takes effect · Acquisition of Sørlie Prosjektinnredninger effective from January 2019 · Rights issue

Recipharm achieves new ISO 45001 certification to support sustainability efforts

Recipharm, the contract development and manufacturing organisation (CDMO), has achieved the new ISO 45001 certification at its Wasserburg facility in Germany. The certification is developed from an earlier certification according to OSHAS 18001 and a result of the Wasserburg facility’s programme to enhance its sustainability and safety efforts. Following an audit in January 2019, the facility, which is one of Recipharm’s sterile manufacturing operations, was recognised for its high calibre occupational health and safety management systems. ISO 45001 is the new working protection

Article about Nexam Chemical in Polymervärlden

The latest issue of the Swedish trade magazine Polymervärlden includes an article about how Nexam Chemical´s products can improve the properties of polymers. Read the article, in Swedish, on the company website www.nexamchemical.com .Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Johan Arvidsson, CEO, +46-708 97 44 39,

Itiviti receives 2019 TradingTech Insight Europe Award for Tbricks

Analytics strength of Tbricks highlighted as Itiviti accepts 2019 TradingTech Insight Europe Award. London, UK, February 28, 2019 – Itiviti, the leading global provider of multi-asset trading technology and financial infrastructure, today announced that it has been named a winner of the acclaimed TradingTech Insight (TTI) Europe Awards for 2019. At the awards ceremony held in London yesterday, Itiviti’s Tbricks was recognized as Best Trading Analytics Platform.Presented by A-Team, the TTI Europe Awards have been designed to acknowledge excellence in trading solutions and services for

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation Stock exchange release, 28 February 2019 at 9 am EETNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation it has crossed above the 5% disclosure limit on shares and voting rights on 26 February 2019. Following the transaction BlackRock, Inc. owns 5.07% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.42%.Total position of BlackRock, Inc. and its funds subject to the notification: +----

Polygiene AB (publ.) Interim Report 1 october–31 december 2018

Streamlining operations and a positive year-endQ4 in brief · The operating income increased with 9,2% during the fourth quarter compared to the same period the last year and amounted to MSEK 18.6 (17.1). Year 2018 was amounted to MSEK 69.0 (66.1). · Operating profit/loss (EBIT) for the period, excluding the sales of the Protective Surfaces business area amounted to MSEK 0.5 (0) and for the whole year, to MSEK -2.8 (-6.1). · As part of a streamlining of the business, the Protective business area has been divested, which brought in revenue of MSEK 10.6. · The cash flow of the

Terveystalo Plc: Report by the Board of Directors, Financial Statements and Corporate Governance Statement 2018 published

Terveystalo Plc Annual Financial Report 28 February at 9:00 am EET Terveystalo has published its Annual Report 2018 at https://www.terveystalo.com/en/annual-review-2018/ . The Annual Report 2018 includes the Report by the Board of Directors, Financial Statements, the Statement of Non-Financial Information and the Corporate Governance Statement. The Annual Report is attached to this release as a separate PDF file. Terveystalo Plc For more information, please contact:Kati Kaksonen, Director, Investor Relations and Financial CommunicationsTel. +358 10 345 2034Kati.kaksonen@

Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2018

Financial Statements ReleaseJanuary 1-December 31, 2018 Progress from safety studies toward clinical proof-of-concept Highlights in January-December 2018: · Herantis Pharma ("Herantis") completed the patient enrolment in the Phase 1 clinical study of Lymfactin in February. · Phase 1-2 clinical study of CDNF expanded in February to the university hospitals of Helsinki and Lund in addition to Stockholm based on a favorable first safety evaluation. · Herantis announced in April positive interim results from its Phase 1 clinical study of Lymfactin® in the treatment of breast

DiviTum provides first biomarker evidence for evaluating palbociclib efficacy in new clinical study presented at AACR

New DiviTum results from a clinical study led by Dr Luca Malorni from the Prato Hospital, Italy will be presented at the American Association of Cancer Research annual meeting, 29 March-3 April, in Atlanta. The study results show that DiviTum can evaluate palbociclib treatment responses in women with breast cancer, supporting the potential of the biomarker as a clinically valuable technology for evaluating the effects of a new, targeted breast cancer therapy.The CDK 4/6 inhibitor, palbociclib, is Pfizer’s successful targeted therapy prescribed to more than 160 000 women with metastatic

Nixu published its 2018 Financial Results - Strong organic growth and preparation for the next steps

Nixu CorporationPress release, February 28, 2019 at 8:35 AM EETEuropean cybersecurity company Nixu has published its financial statements release on February 28, 2019 and the English translation of the release is available on the company’s website at: https://www.nixu.com/release/financial-statements-release-january-1-december-31-2018-ifrs Petri Kairinen, Nixu CEO, commented on the results, “While cybersecurity was frequently in the headlines in 2018 with the emergence of increased transparency of regulation and recurring data breaches, the financial year 2018 was once again a year of

There are no items matching the current filter
There are no more items matching the current filter
Back to top